SCHEMBL6674094

SCHEMBL6674094

CC(C)CC1CN(C(=O)O)CCc2cc(OC3CCN(C(C)C)CC3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6672764 0.89 F10 (0.45) HRH3
SCHEMBL6673742 0.87 F10 (0.44) HRH3
SCHEMBL6674048 0.84 F10 (0.50) —
SCHEMBL5551732 0.84 MTNR1B (0.50) —
SCHEMBL6674092 0.83 HRH3 (0.48) HRH3
SCHEMBL2121245 0.79 DRD2 (0.38) —
SCHEMBL4637685 0.79 NR1H2 (0.39) —
SCHEMBL5165139 0.78 GRIN1 (0.54) HRH3
SCHEMBL2124647 0.78 ESR1 (0.44) —
SCHEMBL5170176 0.76 SLC18A2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004035544-A1 BENZO[D]AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS GLAXO GROUP LIMITED (GB) 2004-04-29 — — WO disclosed
Send feedback